Description
REVLIMID TAB 10MG
First action · last action
2010-11-22 · 2010-11-22
Transactions
1
First transaction's obligation
$3,810
Base + all options value (sum of deltas)
$3,810
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-11-22+$3,810= $3,810
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-11-22 | +$3,810 | $3,810 | REVLIMID TAB 10MG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HRE3UMLEM2P5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24922P0128 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $18,520 | FY2022 |
| 36C24922P0070 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $18,520 | FY2022 |
| 36C79119N0016 | STRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G) · Q517 · MEDICAL- PHARMACOLOGY | $3,253,600 | FY2019 |
| 36C79119D0032 | COMMODITIES & SERVICES ACQUISITION SERVICE (36C791) · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2019 |
| 36C24519P0773 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $94,972 | FY2019 |
| 36C24519P0425 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $47,486 | FY2019 |
Other recipients under 6505 from 516-BAY PINES (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24812F4468 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 516-BAY PINES | $126,320 | FY2012 |
| VA24812F4429 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 516-BAY PINES | $66,125 | FY2012 |
| VA24812F3711 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 516-BAY PINES | $6,653 | FY2012 |
| VA24812F3681 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 516-BAY PINES | $5,544 | FY2012 |
| VA24812F3824 | ABBOTT LABORATORIES INC. | 516-BAY PINES | $53,050 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA516A10120_3600_-NONE-_-NONE- · retrieved 2026-09-26.